AZN.L - AstraZeneca PLC

LSE - LSE Delayed price. Currency in GBp
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
Currency in USD. All numbers in thousands
Revenue31/12/201831/12/201731/12/201631/12/2015
Total revenue22,090,00022,465,00023,002,00024,708,000
Cost of revenue4,504,0004,137,0003,996,0004,488,000
Gross profit17,586,00018,328,00019,006,00020,220,000
Operating expenses
Research development5,299,0005,455,0005,679,0005,660,000
Selling general and administrative10,803,0009,505,0009,902,00011,024,000
Non-recurring----
Others-266,000-219,000-322,000-535,000
Total operating expenses20,340,00018,878,00019,255,00020,637,000
Operating income or loss1,750,0003,587,0003,747,0004,071,000
Income from continuing operations
Total other income/expenses net243,000-1,360,000-195,000-1,002,000
Earnings before interest and taxes1,750,0003,587,0003,747,0004,071,000
Interest expense-744,000-664,000-617,000-392,000
Income before tax1,993,0002,227,0003,552,0003,069,000
Income tax expense-57,000-641,000146,000243,000
Minority interest1,576,0001,682,0001,815,00019,000
Net income from continuing ops2,050,0002,868,0003,406,0002,826,000
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income2,155,0003,001,0003,499,0002,825,000
Preferred stock and other adjustments----
Net income applicable to common shares2,155,0003,001,0003,499,0002,825,000
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes